AM-Pharma   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bunnik Utrecht Netherlands (2000)

Organization Overview

First Clinical Trial
2004
NCT00430859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AM-Pharma | AM Pharma BV